2018-2023 Global Oxaliplatin Consumption Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Oxaliplatin market for 2018-2023.
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Teva and Jiangsu Hengrui Medicine.
The technological level of Oxaliplatin in China has a big gap compared with the international advanced level. Outstanding performance in product application performance is not outstanding, function is not strong, supporting enough, clean low level, product updates slow, long development cycle. There is little Oxaliplatin performance in China at or near the international advanced level.
Over the next five years, LPI(LP Information) projects that Oxaliplatin will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxaliplatin market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Oxaliplatin market for 2018-2023.
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Teva and Jiangsu Hengrui Medicine.
The technological level of Oxaliplatin in China has a big gap compared with the international advanced level. Outstanding performance in product application performance is not outstanding, function is not strong, supporting enough, clean low level, product updates slow, long development cycle. There is little Oxaliplatin performance in China at or near the international advanced level.
Over the next five years, LPI(LP Information) projects that Oxaliplatin will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxaliplatin market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- Mannitol
- Glucose Solution
- Lactose Solution
- Other
- Colorectal Cancer
- Stomach Cancer
- Ovarian Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi-Aventis
- Yakult honsha
- Dr Reddy's laboratories
- Sun Pharmaceutical
- Teva
- Fresenius Kabi
- Hospira
- Mylan
- Jiangsu Hengrui Medicine
- Nanjing Pharmaceutical Factory
- Jiangsu Aosaikang Pharmaceutical
- Qilu Pharmaceutical
- Hisun Pharmaceutical
- Lunan Pharmaceutical
- Luoxin
- Halfsky Pharmacy
- YRPG
- Hainan Jinrui Pharmaceutical
- Jari Pharmaceutical
- Chiatai Tianqing
Research objectives
- To study and analyze the global Oxaliplatin consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Oxaliplatin market by identifying its various subsegments.
- Focuses on the key global Oxaliplatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Oxaliplatin with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Oxaliplatin submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oxaliplatin Consumption 2013-2023
2.1.2 Oxaliplatin Consumption CAGR by Region
2.2 Oxaliplatin Segment by Type
2.2.1 Mannitol
2.2.2 Glucose Solution
2.2.3 Lactose Solution
2.2.4 Other
2.3 Oxaliplatin Consumption by Type
2.3.1 Global Oxaliplatin Consumption Market Share by Type (2013-2018)
2.3.2 Global Oxaliplatin Revenue and Market Share by Type (2013-2018)
2.3.3 Global Oxaliplatin Sale Price by Type (2013-2018)
2.4 Oxaliplatin Segment by Application
2.4.1 Colorectal Cancer
2.4.2 Stomach Cancer
2.4.3 Ovarian Cancer
2.4.4 Other
2.5 Oxaliplatin Consumption by Application
2.5.1 Global Oxaliplatin Consumption Market Share by Application (2013-2018)
2.5.2 Global Oxaliplatin Value and Market Share by Application (2013-2018)
2.5.3 Global Oxaliplatin Sale Price by Application (2013-2018)
3 GLOBAL OXALIPLATIN BY PLAYERS
3.1 Global Oxaliplatin Sales Market Share by Players
3.1.1 Global Oxaliplatin Sales by Players (2016-2018)
3.1.2 Global Oxaliplatin Sales Market Share by Players (2016-2018)
3.2 Global Oxaliplatin Revenue Market Share by Players
3.2.1 Global Oxaliplatin Revenue by Players (2016-2018)
3.2.2 Global Oxaliplatin Revenue Market Share by Players (2016-2018)
3.3 Global Oxaliplatin Sale Price by Players
3.4 Global Oxaliplatin Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Oxaliplatin Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Oxaliplatin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 OXALIPLATIN BY REGIONS
4.1 Oxaliplatin by Regions
4.1.1 Global Oxaliplatin Consumption by Regions
4.1.2 Global Oxaliplatin Value by Regions
4.2 Americas Oxaliplatin Consumption Growth
4.3 APAC Oxaliplatin Consumption Growth
4.4 Europe Oxaliplatin Consumption Growth
4.5 Middle East & Africa Oxaliplatin Consumption Growth
5 AMERICAS
5.1 Americas Oxaliplatin Consumption by Countries
5.1.1 Americas Oxaliplatin Consumption by Countries (2013-2018)
5.1.2 Americas Oxaliplatin Value by Countries (2013-2018)
5.2 Americas Oxaliplatin Consumption by Type
5.3 Americas Oxaliplatin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Oxaliplatin Consumption by Countries
6.1.1 APAC Oxaliplatin Consumption by Countries (2013-2018)
6.1.2 APAC Oxaliplatin Value by Countries (2013-2018)
6.2 APAC Oxaliplatin Consumption by Type
6.3 APAC Oxaliplatin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Oxaliplatin by Countries
7.1.1 Europe Oxaliplatin Consumption by Countries (2013-2018)
7.1.2 Europe Oxaliplatin Value by Countries (2013-2018)
7.2 Europe Oxaliplatin Consumption by Type
7.3 Europe Oxaliplatin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oxaliplatin by Countries
8.1.1 Middle East & Africa Oxaliplatin Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Oxaliplatin Value by Countries (2013-2018)
8.2 Middle East & Africa Oxaliplatin Consumption by Type
8.3 Middle East & Africa Oxaliplatin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Oxaliplatin Distributors
10.3 Oxaliplatin Customer
11 GLOBAL OXALIPLATIN MARKET FORECAST
11.1 Global Oxaliplatin Consumption Forecast (2018-2023)
11.2 Global Oxaliplatin Forecast by Regions
11.2.1 Global Oxaliplatin Forecast by Regions (2018-2023)
11.2.2 Global Oxaliplatin Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oxaliplatin Forecast by Type
11.8 Global Oxaliplatin Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Sanofi-Aventis
12.1.1 Company Details
12.1.2 Oxaliplatin Product Offered
12.1.3 Sanofi-Aventis Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Sanofi-Aventis News
12.2 Yakult honsha
12.2.1 Company Details
12.2.2 Oxaliplatin Product Offered
12.2.3 Yakult honsha Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Yakult honsha News
12.3 Dr Reddy's laboratories
12.3.1 Company Details
12.3.2 Oxaliplatin Product Offered
12.3.3 Dr Reddy's laboratories Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Dr Reddy's laboratories News
12.4 Sun Pharmaceutical
12.4.1 Company Details
12.4.2 Oxaliplatin Product Offered
12.4.3 Sun Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sun Pharmaceutical News
12.5 Teva
12.5.1 Company Details
12.5.2 Oxaliplatin Product Offered
12.5.3 Teva Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Teva News
12.6 Fresenius Kabi
12.6.1 Company Details
12.6.2 Oxaliplatin Product Offered
12.6.3 Fresenius Kabi Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Fresenius Kabi News
12.7 Hospira
12.7.1 Company Details
12.7.2 Oxaliplatin Product Offered
12.7.3 Hospira Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Hospira News
12.8 Mylan
12.8.1 Company Details
12.8.2 Oxaliplatin Product Offered
12.8.3 Mylan Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Mylan News
12.9 Jiangsu Hengrui Medicine
12.9.1 Company Details
12.9.2 Oxaliplatin Product Offered
12.9.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Jiangsu Hengrui Medicine News
12.10 Nanjing Pharmaceutical Factory
12.10.1 Company Details
12.10.2 Oxaliplatin Product Offered
12.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Nanjing Pharmaceutical Factory News
12.11 Jiangsu Aosaikang Pharmaceutical
12.12 Qilu Pharmaceutical
12.13 Hisun Pharmaceutical
12.14 Lunan Pharmaceutical
12.15 Luoxin
12.16 Halfsky Pharmacy
12.17 YRPG
12.18 Hainan Jinrui Pharmaceutical
12.19 Jari Pharmaceutical
12.20 Chiatai Tianqing
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oxaliplatin Consumption 2013-2023
2.1.2 Oxaliplatin Consumption CAGR by Region
2.2 Oxaliplatin Segment by Type
2.2.1 Mannitol
2.2.2 Glucose Solution
2.2.3 Lactose Solution
2.2.4 Other
2.3 Oxaliplatin Consumption by Type
2.3.1 Global Oxaliplatin Consumption Market Share by Type (2013-2018)
2.3.2 Global Oxaliplatin Revenue and Market Share by Type (2013-2018)
2.3.3 Global Oxaliplatin Sale Price by Type (2013-2018)
2.4 Oxaliplatin Segment by Application
2.4.1 Colorectal Cancer
2.4.2 Stomach Cancer
2.4.3 Ovarian Cancer
2.4.4 Other
2.5 Oxaliplatin Consumption by Application
2.5.1 Global Oxaliplatin Consumption Market Share by Application (2013-2018)
2.5.2 Global Oxaliplatin Value and Market Share by Application (2013-2018)
2.5.3 Global Oxaliplatin Sale Price by Application (2013-2018)
3 GLOBAL OXALIPLATIN BY PLAYERS
3.1 Global Oxaliplatin Sales Market Share by Players
3.1.1 Global Oxaliplatin Sales by Players (2016-2018)
3.1.2 Global Oxaliplatin Sales Market Share by Players (2016-2018)
3.2 Global Oxaliplatin Revenue Market Share by Players
3.2.1 Global Oxaliplatin Revenue by Players (2016-2018)
3.2.2 Global Oxaliplatin Revenue Market Share by Players (2016-2018)
3.3 Global Oxaliplatin Sale Price by Players
3.4 Global Oxaliplatin Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Oxaliplatin Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Oxaliplatin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 OXALIPLATIN BY REGIONS
4.1 Oxaliplatin by Regions
4.1.1 Global Oxaliplatin Consumption by Regions
4.1.2 Global Oxaliplatin Value by Regions
4.2 Americas Oxaliplatin Consumption Growth
4.3 APAC Oxaliplatin Consumption Growth
4.4 Europe Oxaliplatin Consumption Growth
4.5 Middle East & Africa Oxaliplatin Consumption Growth
5 AMERICAS
5.1 Americas Oxaliplatin Consumption by Countries
5.1.1 Americas Oxaliplatin Consumption by Countries (2013-2018)
5.1.2 Americas Oxaliplatin Value by Countries (2013-2018)
5.2 Americas Oxaliplatin Consumption by Type
5.3 Americas Oxaliplatin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Oxaliplatin Consumption by Countries
6.1.1 APAC Oxaliplatin Consumption by Countries (2013-2018)
6.1.2 APAC Oxaliplatin Value by Countries (2013-2018)
6.2 APAC Oxaliplatin Consumption by Type
6.3 APAC Oxaliplatin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Oxaliplatin by Countries
7.1.1 Europe Oxaliplatin Consumption by Countries (2013-2018)
7.1.2 Europe Oxaliplatin Value by Countries (2013-2018)
7.2 Europe Oxaliplatin Consumption by Type
7.3 Europe Oxaliplatin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oxaliplatin by Countries
8.1.1 Middle East & Africa Oxaliplatin Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Oxaliplatin Value by Countries (2013-2018)
8.2 Middle East & Africa Oxaliplatin Consumption by Type
8.3 Middle East & Africa Oxaliplatin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Oxaliplatin Distributors
10.3 Oxaliplatin Customer
11 GLOBAL OXALIPLATIN MARKET FORECAST
11.1 Global Oxaliplatin Consumption Forecast (2018-2023)
11.2 Global Oxaliplatin Forecast by Regions
11.2.1 Global Oxaliplatin Forecast by Regions (2018-2023)
11.2.2 Global Oxaliplatin Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oxaliplatin Forecast by Type
11.8 Global Oxaliplatin Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Sanofi-Aventis
12.1.1 Company Details
12.1.2 Oxaliplatin Product Offered
12.1.3 Sanofi-Aventis Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Sanofi-Aventis News
12.2 Yakult honsha
12.2.1 Company Details
12.2.2 Oxaliplatin Product Offered
12.2.3 Yakult honsha Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Yakult honsha News
12.3 Dr Reddy's laboratories
12.3.1 Company Details
12.3.2 Oxaliplatin Product Offered
12.3.3 Dr Reddy's laboratories Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Dr Reddy's laboratories News
12.4 Sun Pharmaceutical
12.4.1 Company Details
12.4.2 Oxaliplatin Product Offered
12.4.3 Sun Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sun Pharmaceutical News
12.5 Teva
12.5.1 Company Details
12.5.2 Oxaliplatin Product Offered
12.5.3 Teva Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Teva News
12.6 Fresenius Kabi
12.6.1 Company Details
12.6.2 Oxaliplatin Product Offered
12.6.3 Fresenius Kabi Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Fresenius Kabi News
12.7 Hospira
12.7.1 Company Details
12.7.2 Oxaliplatin Product Offered
12.7.3 Hospira Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Hospira News
12.8 Mylan
12.8.1 Company Details
12.8.2 Oxaliplatin Product Offered
12.8.3 Mylan Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Mylan News
12.9 Jiangsu Hengrui Medicine
12.9.1 Company Details
12.9.2 Oxaliplatin Product Offered
12.9.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Jiangsu Hengrui Medicine News
12.10 Nanjing Pharmaceutical Factory
12.10.1 Company Details
12.10.2 Oxaliplatin Product Offered
12.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Nanjing Pharmaceutical Factory News
12.11 Jiangsu Aosaikang Pharmaceutical
12.12 Qilu Pharmaceutical
12.13 Hisun Pharmaceutical
12.14 Lunan Pharmaceutical
12.15 Luoxin
12.16 Halfsky Pharmacy
12.17 YRPG
12.18 Hainan Jinrui Pharmaceutical
12.19 Jari Pharmaceutical
12.20 Chiatai Tianqing
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Oxaliplatin
Table Product Specifications of Oxaliplatin
Figure Oxaliplatin Report Years Considered
Figure Market Research Methodology
Figure Global Oxaliplatin Consumption Grow
Figure Picture of Oxaliplatin
Table Product Specifications of Oxaliplatin
Figure Oxaliplatin Report Years Considered
Figure Market Research Methodology
Figure Global Oxaliplatin Consumption Grow
